MedTrace Logo

AV Node Isolation in Atrial Fibrillation vs. Modulation by "Pace and Ablate" Strategy

NCT04859933 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2022-08-09

No results posted yet for this study

Summary

AV-node ablation (AVNA) is a common therapy option for rate control strategy of permanent atrial fibrillation with numerous side effects. The investigators hypothesised that an isolation of the AV node is concomitant with less occurrence of new bundle brunch blocks, more frequent preservation and higher rate of escape rhythm compared to AVNA. This retrospective study includes 20 patients being treated with AV-node isolation (AVNI) and 40 historical AVNA-controls. Among others these two methods were compared regarding escape rhythm, delta QRS, procedure time, ablation points, fluoroscopy time and total dose area product (DAP).

Conditions

Interventions

PROCEDURE

AV-node isolation

Abaltion performed in the right atrium isolating the AV-node from the atrium

PROCEDURE

AV-node ablation

Right sided ablation of the AV-node

Sponsors & Collaborators

  • Heart and Diabetes Center North-Rhine Westfalia

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04859933 on ClinicalTrials.gov